Survey Reveals Most People with SMA Using New Gene Therapies
Three-fourths of survey respondents said they currently use an “SMN-enhancing” treatment, while another 19% said they previously used one.
Three-fourths of survey respondents said they currently use an “SMN-enhancing” treatment, while another 19% said they previously used one.
These key hirings bring experience and expertise that will enhance and extend the value of Health Union’s business model and offerings.
The aim of Health Union’s research was to determine how using MG-specific community resources may impact patients’ perceptions of their health journey.
The Social Health Awards empower and celebrate health leaders who are essential to the ongoing conversations and connections made through social health.
Nearly a fifth of Thyroid Eye Disease In America survey respondents said people have assumed they are hungover due to their thyroid eye disease symptoms.
56% of survey respondents living with respiratory allergies and 46% living with food allergies have currently or previously used immunotherapy.
This recognition reflects Health Union’s ongoing and impressive growth and continues an achievement first commemorated by the Inc. 5000 in 2018.
Nearly six in 10 NMOSD In America survey respondents said being part of an online community of people living with NMOSD has helped them feel less alone.
Three in 10 Chronic Hives In America survey respondents said they considered their chronic hives to be controlled on their current treatment plan.
Social Health Awards nominations are open to patient leaders who are active, leading members of an online community and making a difference in healthcare.